Experience with lamivudine treatment for severe acute hepatitis B
Introduction. Experience with lamivudine treatment for acute severe hepatitis B is limited. Fulminant hepatitis develops in 1% of immunocompetent patients with acute hepatitis B. Objective. The aim of this study was to evaluate the efficacy of lamivudine in the treatment of severe acute hep...
Main Author: | Verhaz Antonija |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2014-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2014/0370-81791412703V.pdf |
Similar Items
-
Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01) -
Treatment of subacute hepatitis B with lamivudine: A pilot study in Serbia
by: Delić Dragan, et al.
Published: (2009-01-01) -
The effects of prolonged Lamivudine administration as a sole treatment following the combination therapy of Interferon Alpha and Lamivudine in children for HBeAg (+) chronic hepatitis B
by: Sezin Asik Akman,1 Sabriye Cokceken Okcu,2 Sumer Sutcuoglu.2
Published: (2007-10-01) -
Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01) -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
by: Jurgen Gerada, et al.
Published: (2013-06-01)